Precision Medicine in Genitourinary Cancers
The world-renowned Genitourinary (GU) Oncology Program at Weill Cornell Medicine is dedicated to providing cutting-edge multidisciplinary treatment at every stage and for every type of prostate, kidney, bladder and testicular cancer.
We view each patient as an individual and use a multidisciplinary approach to ensure that each treatment regimen is narrowly tailored to meet the unique needs of the patient and his or her diagnosis.
New patients are discussed weekly at a multidisciplinary GU Oncology Tumor Board, which allows us to collaborate with experts in other cancer sub-specialty areas in order to ensure that our patients are receiving the best, most comprehensive treatment.
Our internationally recognized GU specialists are known for advanced work and published research in:
- Precision medicine, providing individualized treatment based on a patient’s genetic profile
- Circulating tumor cells and other biomarkers that can predict cancer prognosis
- Targeted immunotherapies, including using monoclonal antibodies that have been specifically engineered in our lab to help your immune system fight your cancer
- Novel treatments for advanced genitourinary cancers
We pride ourselves on exceptional outcomes and offer patients the most advanced diagnostic methods and treatment therapies, including advanced tumor imaging, molecular imaging, minimally invasive surgery, radiation, chemotherapy, immunotherapy, targeted therapy, combination therapy and precision medicine tumor profiling.
Our patients have access to many multi-phase clinical trials at all stages of testicular, bladder, kidney, and prostate cancer.
As active members of the international cancer research community, our oncologists also collaborate with other research centers to offer patients the most promising treatments available.